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Abstract
Available data suggest that the Varicella-Zoster virus (VZV) IE4 protein acts as an important regulator on VZV and cellular
genes expression and could exert its functions at post-transcriptional level. However, the molecular mechanisms supported
by this protein are not yet fully characterized. In the present study, we have attempted to clarify this IE4-mediated gene
regulation and identify some cellular partners of IE4. By yeast two-hybrid and immunoprecipitation analysis, we showed
that IE4 interacts with three shuttling SR proteins, namely ASF/SF2, 9G8 and SRp20. We positioned the binding domain in
the IE4 RbRc region and we showed that these interactions are not bridged by RNA. We demonstrated also that IE4 strongly
interacts with the main SR protein kinase, SRPK1, and is phosphorylated in in vitro kinase assay on residue Ser-136 contained
in the Rb domain. By Northwestern analysis, we showed that IE4 is able to bind RNA through its arginine-rich region and in
immunoprecipitation experiments the presence of RNA stabilizes complexes containing IE4 and the cellular export factors
TAP/NXF1 and Aly/REF since the interactions are RNase-sensitive. Finally, we determined that IE4 influences the export of
reporter mRNAs and clearly showed, by TAP/NXF1 knockdown, that VZV infection requires the TAP/NXF1 export pathway to
express some viral transcripts. We thus highlighted a new example of viral mRNA export factor and proposed a model of
IE4-mediated viral mRNAs export.
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Introduction
In eukaryotic cells, export of mRNAs from the nucleus into the
cytoplasm is a complex and well regulated process. In metazoans,
mature mRNPs are transported by the essential mRNA export
receptor TAP/NXF1 that shuttles between the nucleus and the
cytoplasm and escorts competent mRNPs out of the nucleus
through direct interactions with nucleoporins lining the nuclear
pore [1]. Because of its low affinity for binding mRNAs, TAP/
NXF1 needs export adaptor proteins to interface with mature
transcripts that are ready for export. So far, the best-characterized
adaptor of TAP/NXF1 is the Aly/REF protein [2]. For its
recruitment to mRNAs, Aly/REF requires the essential mRNA
export factor UAP56 [3] and these two proteins were originally
found to be associated with the exon junction complex (EJC)
formed during late stage of pre-mRNA splicing [4]. More recent
studies have shown that UAP56 and Aly/REF are part of the
multi-protein TREX (transcription-export) complex, which is
recruited co-transcriptionally to the 59 end of mRNAs via the
cap-binding protein Cbp80 [5] and is essential for the export of
both spliced and intronless mRNAs [6,7]. While UAP56 was
shown to be essential for mRNA export in both Drosophila and C.
elegans, Aly/REF seems to be dispensable, suggesting the existence
of additional mRNA export adaptors [8,9]. Moreover, it has been
speculated that the shuttling SR proteins SRp20, 9G8 and ASF/
SF2, retained on mRNAs, might also generate export-competent
mRNPs. Interestingly, shuttling SR proteins have been shown to
promote export of both intronless [10] and intron-containing [11]
mRNAs. Thus, these proteins may be export adaptors shared by
different mRNA classes. This hypothesis is supported by the fact
that, like the adaptor Aly/REF, shuttling SR proteins can directly
interact with TAP/NXF1 and can recruit this export receptor to
bound mRNAs [12].
In case of a viral infection, in addition to cellular mRNAs,
amounts of viral mRNAs have to be efficiently transported to the
cytoplasm for translation. For this, several viruses use a similar
strategy that involves specific cis-acting RNA elements within the
intronless transcripts. Among the herpesviral genes, only one cis-
acting RNA element for mRNA export has been actually
described [13]. Instead, it is now established that herpesviruses
encode a conserved gene family whose proteins act as viral mRNA
export factors that mediate nucleocytoplasmic transport of viral
transcripts [14]. This conserved family of proteins contains the
ICP27 protein of herpes simplex virus type 1 (HSV-1), the UL69
protein of human cytomegalovirus (HCMV), and the EB2 protein
of Epstein-Barr virus (EBV), respectively alpha-, beta- and
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gamma-herpesviruses. The principal characteristics of these viral
mRNA export factors are a nucleocytoplasmic shuttling activity,
an RNA-binding domain and the capacity to interact with cellular
mRNA export factors.
Varicella-Zoster virus (VZV) is another alpha-herpesvirus
encoding the IE4 protein which is homologous to the proteins
described above. IE4 is rapidly produced during the first stages of
infection, suggesting that it functions as an important regulator of
VZV and/or cellular genes expression. The construction of IE4
knockout virus has shown that IE4 is essential for infection and has
an important role in latency establishment [15,16,17]. However,
the molecular mechanisms supported by this protein are not yet
fully characterized. Based on its amino acid sequence, IE4 can be
divided into four different regions (Figure 1A): (i) an acidic region
located at the amino-terminal part of the protein; (ii) an arginine-
rich region, also located near the N-terminus, divided into three
domains called Ra, Rb and Rc; (iii) a central region; and (iv) a
cystein-rich region at the C-terminus. Even if several domains
seem to be multifunctional, general tendencies have been
highlighted [18]: the arginine-rich domains Rb and Rc were
demonstrated to be important for transactivation properties and
protein-protein interactions, a nuclear localization signal (NLS)
was identified within the Rb domain, and the carboxy-terminal
region was also shown to be crucial for the dimerization and the
cytoplasmic distribution of the protein. Although IE4 has been so
far described as a transcriptional activator [19,20,21], its proper
localization seems to be crucial for its regulatory properties, and it
could be hypothesized that IE4 might exert other functions
through post-transcriptional mechanisms [22], mediated by its
shuttling between the cytoplasm and the nucleus.
In this report, we showed that IE4 interacts with three shuttling
SR proteins, namely ASF/SF2, 9G8 and SRp20, in a yeast two-
hybrid screen as well as in a cellular context. We identified the SR
protein interaction domain within IE4 and demonstrated that this
domain is phosphorylated by the SR protein kinase SRPK1. We
showed also that IE4 is found in complexes containing TAP/
NXF1 and Aly/REF, and that these complexes are stabilized by
RNA since the interactions are RNase-sensitive. Finally, we
established the role of IE4 in mRNA export and showed that VZV
viral transcripts are exported through the TAP/NXF1 pathway.
Figure 1. Construction of various IE4 deletants and mutants. (A) Schematic representation of the 452-amino acid coding region of IE4. The N-
terminal acid-rich region (Acid Rich), the three arginine-rich regions (Ra, Rb and Rc), the central part (Central) and the C-terminal cysteine-rich domain
(Cys Rich) are illustrated. (B) The RbRc yeast two-hybrid bait, (C) the multiple carboxy V5 epitope-tagged constructs as well as (D) the different amino
GST fusion proteins are depicted.
doi:10.1371/journal.pone.0007882.g001
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Results
IE4 interacts with ASF/SF2, 9G8 and SRp20
In order to clarify the molecular mechanisms involved in IE4-
mediated gene regulation and to identify IE4 potential cellular
partners, a HeLa cDNA library was screened by yeast two-hybrid
analysis. The region encompassing the arginine-rich Rb and Rc
domains was chosen for this screening (Figure 1B). These domains
have been shown to be important for transactivation, protein-
protein interactions and proper localization of IE4 [18] and are
therefore good candidates for the identification of cellular
partners. In this experiment, 70 colonies grew on histidine-lacking
media and produced b-galactosidase, meeting the criteria for
positive interaction. From these colonies, 38 different proteins
were highlighted, and among these the predominant category
corresponds to proteins involved in RNA metabolism, which
strongly suggests a post-transcriptional implication of IE4 in gene
regulation. Three of the identified proteins, ASF/SF2, SRp20 and
9G8, are members of the highly conserved SR protein family.
To further study the interaction between IE4 and these three
splicing factors, co-immunoprecipitation experiments were carried
out (Figure 2A). HeLa cells were co-transfected with pcDNA3.1/
V5-His-TOPO-IE4 and pCMV-HA-ASF/SF2, 9G8 or SRp20 as
indicated, and either IE4 or the SR proteins were immunopre-
cipitated from nuclear extracts with anti-V5 or anti-HA
antibodies. Immunoprecipitation efficiency was checked
(Figure 2A, lanes 2 and 8) and negative controls were performed
without (Figure 2A, lanes 3 and 9) or with an irrelevant antibody
(Figure 2A, lanes 4 and 10). We showed that the three SR proteins
are co-precipitated with IE4 (Figure 2A, lane 5) and that IE4
efficiently precipitates with the three splicing factors, no matter
which partner was immunoprecipitated (Figure 2A, lane 11). To
determine whether or not this interaction was mediated by RNA,
we performed these co-immunoprecipitation experiments after
treatment of the nuclear extracts with a mix of RNases A/T1. The
three splicing factors still co-precipitate with IE4 in the presence of
RNase (Figure 2A, lane 6), indicating that this interaction is not
bridged by RNA.
To further confirm this interaction, co-immunoprecipitation
experiments of endogenous SR proteins were also carried out
(Figure 2B). HeLa cells were transfected with pcDNA3.1/V5-His-
TOPO-IE4 and IE4 was immunoprecipitated from total extracts
with anti-V5 antibody. Immunoprecipitation efficiency was
checked (Figure 2B, lower panels, lanes 4 and 8) and negative
control was performed with an irrelevant antibody (Figure 2B,
lanes 3 and 7). We showed that endogenous ASF/SF2 and SRp20
are co-precipitated with IE4 (Figure 2B, upper panels, lanes 4
and 8).
The arginine-rich region of IE4 is involved in this
interaction
To determine more precisely the region of IE4 that is involved
in this interaction, in vitro binding assays were performed by using
GST fusion proteins and 35S-proteins that were in vitro translated
in reticulocyte lysates. The different V5-tagged constructs
(Figure 1C) were 35S-labelled and incubated with GST-ASF/
SF2-coupled Sepharose beads (Figure 2C). Assay performed with
GST alone constituted the negative control (Figure 2C, lane 1).
Even if the amounts of translated 35S-labelled IE4 Nter-V5 (*) and
Cter-V5 (**) (Figure 2C, lanes 10 and 11) are much lower than the
others (Figure 2C, lanes 8 to 14), it clearly appears that IE4 Nter-
V5 (Figure 2C, lane 3), as the full-length protein (Figure 2C, lane
2), is retained by the GST-ASF/SF2 fusion protein whereas IE4
Cter-V5 is not able to interact with the splicing factor (Figure 2C,
lane 4), indicating that the interaction domain is exclusively
located in the N-terminal part of IE4. Deletion of the acid-rich
region as well as the cysteine-rich domain, involved in IE4
dimerization, does not affect this interaction as IE4 DAcid-V5
(Figure 2C, lane 5) and DCys-V5 (Figure 2C, lane 6) still bind the
SR protein. Surprisingly, IE4 DRbRc-V5, lacking the region used
as bait in our yeast two-hybrid screen, is slightly retained by the
GST fusion protein (Figure 2C, lane 7), suggesting that a
surrounding region could be involved in the interaction with the
splicing factor. Similar results were obtained in presence of GST-
9G8 and GST-SRp20-coupled Sepharose beads (data not shown).
In order to target more precisely this interaction domain, GST
fusion proteins containing distinct IE4 domains (Figure 1D) were
incubated with 35S-labelled ASF/SF2-V5 (Figure 2D). GST-IE4
Nter was shown to interact with this SR protein (Figure 2D, lane
2), while GST-IE4 Cter was not (Figure 2D, lane 3). We also
showed that the acid-rich region fails to retain ASF/SF2-V5
(Figure 2D, lane 4), while the Rb and Rc domains strongly interact
(Figure 2D, lanes 6 and 7). Interestingly, the Ra domain is also
able to weakly interact (Figure 2D, lane 5). In the same
experiment, the Ra domain slightly interacts with 35S-labelled
9G8-V5 and SRp20-V5 (data not shown), explaining why the IE4
DRbRc-V5 still interacts with the three SR proteins (Figure 2C).
We thus concluded that IE4 interacts with ASF/SF2, 9G8 and
SRp20 through its arginine-rich Rb, Rc and, to a lesser extent, Ra
domains.
IE4 is phosphorylated in vitro by SRPK1
SR proteins are known to be phosphorylated by SR protein
kinases, such as SRPK1 [23]. Their interactions with other
proteins and RNA as well as their activities are indeed precisely
regulated by their phosphorylation level. In this context, the ability
of IE4 to be a substrate of this kinase was investigated. In silico
analysis of IE4 amino acid sequence, using NetPhosK 1.0
prediction tool software [24], revealed the presence in the Rb
domain of three RS/SR dipeptides (Figure 3A) that resemble the
SRPK1 yeast homolog Sky1p site identified in Np13p [25]. In
order to determine whether IE4 was phosphorylated by SRPK1, in
vitro kinase assays were performed (Figure 3B). The different GST
fusion parts of IE4 (Figure 1D) were used as substrates and were
incubated with either recombinant SRPK1 (Figure 3B, upper
panel) or purified His-SRPK1 (Figure 3B, middle panel). GST
alone was used as negative control (Figure 3B, lane 1). We clearly
showed that the GST-IE4 Nter can be used as an SRPK1
substrate in vitro (Figure 3B, lane 2), whereas GST-IE4 Cter is not
phosphorylated (Figure 3B, lane 3). This phosphorylation was
shown to be restricted to the IE4 N-terminal Rb domain
(Figure 3B, lane 9), confirming the in silico analysis, since GST-
IE4 Acid, Ra and Rc are not phosphorylated (Figure 3B, lanes 7, 8
and 10). To target the precise phosphorylation site, the three
potential phosphorylable serine residues were substituted by
alanine (Figure 1D), and the mutated proteins were used in the
same in vitro kinase assays. We showed that S120A and S121A
mutations have no significant influence on the phosphorylation
level (Figure 3B, lanes 4 and 5) while S136A mutation almost
abolishes the IE4 phosphorylation by recombinant SRPK1
(Figure 3B, upper panel, lane 6). However, a residual phosphor-
ylation can still be seen on the S136A mutant in presence of
purified His-SRPK1 (Figure 3B, middle panel, lane 6). This could
be explained by the fact that purification of His-SRPK1 from
eukaryotic cells allows the presence of remaining cellular extracts,
including other putative IE4 kinases which could be responsible
for this weak phosphorylation. From these experiments, we can
VZV IE4 as mRNA Export Factor
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conclude that Ser-136 residue is the only amino acid phosphor-
ylated in vitro by both recombinant and cellular SRPK1.
IE4 interacts with SRPK1
To address the ability of IE4 to interact with SRPK1 in the
context of a VZV infection, co-immunoprecipitation experiments
were carried out (Figure 4A). IE4 and SRPK1 were immunopre-
cipitated from total extracts of pFlag-SRPK1-transfected and
mock- or VZV-infected MeWo cells with specific antibodies as
indicated. Irrelevant anti-GFP (Figure 4A, upper panels, lanes 3
and 5) and anti-V5 (Figure 4A, lower panels, lanes 3 and 5)
antibodies were used as negative controls. Obviously, IE4 was
Figure 2. IE4 interacts with ASF/SF2, 9G8 and SRp20 through its arginine-rich Ra, Rb and Rc domains. (A) Nuclear extracts from co-
transfected HeLa cells were immunoprecipitated with anti-GFP, anti-V5 or anti-HA antibodies as indicated. In Input (lanes 1 and 7), nuclear extracts
were fractionated without immunoprecipitation. Nuclear extracts were treated (lane 6) or not (lane 5) with RNases A/T1 mix for 30 min at 37uC before
immunoprecipitation. In lanes 3 and 9, immunoprecipitation was performed with beads without antibody as a negative control (2). The blots were
probed with anti-HA (left panels) or anti-V5 (right panels) antibodies. (B) Total extracts from transfected HeLa cells were immunoprecipitated with
anti-Flag or anti-V5 antibodies as indicated. In Input (lanes 1, 2, 5 and 6), total extracts were fractionated without immunoprecipitation. The blots
were probed with anti-ASF/SF2 or anti-SRp20 (upper panels) and anti-V5 (lower panels) antibodies. The asterisk marks heavy chain IgG from the
immunoprecipitation. (C) In vitro binding assay was performed by incubating GST-ASF/SF2 with in vitro-translated IE4-V5 or derivatives as indicated
(lanes 2 to 7). Assay performed with GST alone constituted the negative control (2) (lane 1). In Input (lanes 8 to 14), [35S]-methionine-labelled
proteins were fractionated without binding assay. (D) In vitro-translated ASF/SF2-V5 was incubated with GST-IE4 derivatives as indicated (lanes 2 to 7).
GST alone constituted the negative control (lane 1) and, in Input, ASF/SF2-V5 was loaded without binding assay (lane 8).
doi:10.1371/journal.pone.0007882.g002
VZV IE4 as mRNA Export Factor
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precipitated only in VZV-infected cells (Figure 4A, upper panels,
lane 6 compared to 4) and Flag-SRPK1 co-precipitates with IE4
(Figure 4A, upper panels, lane 6). Reciprocally, Flag-SRPK1 is
efficiently precipitated by the anti-Flag antibody (Figure 4A, lower
panels, lanes 4 and 6) and IE4 co-precipitates with Flag-SRPK1 in
VZV-infected cells (Figure 4A, lower panels, lane 6).
To map the region of IE4 required for this interaction with
the kinase SRPK1, binding assays were performed by using the
different GST-IE4 fusion proteins (Figure 1D) incubated with
HEK293 cells total extracts (Figure 4B). GST alone was used as
a negative control (Figure 4B, lane 1). We showed that
endogenous SRPK1 is retained by GST-IE4 Nter, Ra and Rb
(Figure 4B, lanes 2, 5 and 6) while not by GST-IE4 Cter, Acid or
Rc (Figure 4B, lanes 3, 4 and 7). Altogether, these results
allowed us to conclude that IE4 interacts with endogenous
SRPK1 through its arginine-rich Ra and Rb domains and that
this interaction domain overlaps partially the SR protein
binding domain.
IE4 interacts with TAP/NXF1 and Aly/REF
Shuttling SR proteins have been proposed to be export adaptors
since, like the adaptor Aly/REF, they were shown to directly
interact with TAP/NXF1 and to recruit this export receptor to
bound mRNAs [11,12]. To determine whether IE4 could be part
of such export-competent mRNPs, interactions between IE4 and
TAP/NXF1 or Aly/REF were first analyzed by in vitro binding
assays. The 35S-labelled V5-tagged IE4 constructs (Figure 1C)
were incubated with GST-TAP- or GST-REF-coupled Sepharose
beads (Figure 5A). We showed that IE4-V5 is retained by both
GST-TAP and GST-REF fusion proteins (Figure 5A, lanes 2 and
9). It appears also clearly that the pattern of interaction is very
similar to that seen with the SR proteins (Figure 2C), since the
interaction occurs through the N-terminal part of IE4 (Figure 5A,
lanes 3 and 10) and is strongly reduced with the IE4 DRbRc
mutant (Figure 5A, lanes 7 and 14).
In order to define whether or not these interactions were
mediated by RNA, the complexes formed in in vitro binding assays
between IE4 Nter-V5 and the GST-TAP or GST-REF were
incubated with a mix of RNases A/T1 (Figure 5B). The
interactions between the IE4 N-terminus and TAP/NXF1 or
Aly/REF were shown to be sensitive to the RNase treatment
(Figure 5B, lanes 5 and 7), indicating that these interactions could
be bridged by RNA.
Figure 3. IE4 is phosphorylated in vitro by SRPK1. (A) The SRPK1
yeast homolog Sky1p site in Np13p as well as the putative SRPK1 sites
in IE4, determined by the NetPhosK 1.0 prediction tool software, are
shown. (B) In vitro kinase assays were performed by incubating
recombinant SRPK1 (upper panel) or purified His-SRPK1 (middle panel)
with GST-IE4 derivatives as substrates (lanes 2 to 10). Assay performed
with GST alone constituted the negative control (lane 1). Coomassie
Blue-stained gel is shown (lower panel).
doi:10.1371/journal.pone.0007882.g003 Figure 4. IE4 interacts with SRPK1 through its arginine-rich Ra
and Rb domains. (A) Total extracts of transfected and mock- or VZV-
infected MeWo cells were immunoprecipitated with anti-GFP, anti-IE4,
anti-V5 or anti-Flag antibodies as indicated (lanes 3 to 6). In Input (lanes
1 and 2), total extracts were fractionated without immunoprecipitation.
The blots were probed with anti-Flag or anti-IE4 antibodies. The asterisk
marks heavy chain IgG from the immunoprecipitation. (B) Binding assay
was performed by incubating HEK293 cells total extracts with GST-IE4
derivatives as indicated (lanes 2 to 7). Assay performed with GST alone
constituted the negative control (lane 1). The blot was probed with
anti-SRPK1 antibody. Coomassie Blue-stained gel is shown below.
doi:10.1371/journal.pone.0007882.g004
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Figure 5. IE4 interacts with TAP/NXF1 and Aly/REF. (A) In vitro binding assays were performed by incubating GST-TAP (lanes 2 to 7) or GST-REF
(lanes 9 to 14) with in vitro-translated IE4-V5 or derivatives as indicated. Assays performed with GST alone constituted the negative control (2) (lanes
1 and 8). (B) In vitro-translated IE4 Nter-V5 was incubated with GST-TAP (lanes 4 and 5) or GST-REF (lanes 6 and 7). GST alone constituted the negative
control (lanes 2 and 3). Complexes were treated (lanes 3, 5 and 7) or not (lanes 2, 4 and 6) with RNases A/T1 mix for 30 min at 37uC before SDS-PAGE.
In Input (lane 1), IE4 Nter-V5 was loaded without binding assay. (C) Total extracts of VZV-infected MeWo cells were immunoprecipitated with anti-GFP
(lane 2), anti-IE4 (lane 3), anti-Flag (lane 5), anti-Aly/REF or anti-TAP/NXF1 (lane 6) antibodies as indicated. In Input (lanes 1 and 4), total extracts were
fractionated without immunoprecipitation. The blots were probed with anti-Aly/REF, anti-TAP/NXF1 or anti-IE4 antibodies. The asterisk marks heavy
chain IgG from the immunoprecipitation. (D) Total extracts of VZV-infected MeWo cells were immunoprecipitated with anti-GFP (lanes 3 and 8), anti-
Aly/REF (lanes 4 and 5) or anti-TAP/NXF1 (lanes 9 and 10) antibodies as indicated. In Input (lanes 1, 2, 6 and 7), total extracts were fractionated
without immunoprecipitation. Total extracts were treated (lanes 5 and 10) or not (lanes 3, 4, 8 and 9) with RNases A/T1 mix for 30 min at 37uC before
immunoprecipitation. The blots were probed with anti-IE4, anti-Aly/REF or anti-TAP/NXF1 antibodies.
doi:10.1371/journal.pone.0007882.g005
VZV IE4 as mRNA Export Factor
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To further study the interaction between IE4 and these two
factors in a context of a VZV infection, co-immunoprecipitation
experiments were carried out (Figure 5C). Either IE4 or
endogenous Aly/REF and TAP/NXF1 were immunoprecipitated
from total extracts of VZV-infected MeWo cells with specific
antibodies as indicated. Immunoprecipitation efficiency was
checked (Figure 5C, lanes 3 and 6) and negative controls were
performed with irrelevant antibodies (Figure 5C, lanes 2 and 5).
We showed that both endogenous Aly/REF and TAP/NXF1
co-precipitate with IE4 (Figure 5C, lane 3) and that reciprocally,
IE4 is efficiently precipitated with Aly/REF and TAP/NXF1
(Figure 5C, lane 6).
To confirm that these interactions were RNA-dependent, we
performed these co-immunoprecipitation experiments after treat-
ment of the total extracts with a mix of RNases A/T1 (Figure 5D).
RNase treatment totally abolishes the interaction between IE4 and
the two factors Aly/REF and TAP/NXF1 (Figure 5D, upper
panels, lanes 5 and 10), confirming that these interactions are
bridged by RNA.
IE4 is able to bind RNA in vitro
As we showed that interactions between IE4 and the two factors
Aly/REF and TAP/NXF1 are RNA-dependent, and to determine
whether or not IE4 is able to directly bind RNA, Northwestern
analysis was performed (Figure 6). Equal amounts of the different
GST-IE4 fusion proteins (Figure 1D) were subjected to SDS-PAGE
and transferred to a PVDF membrane. This membrane was then
incubated with a 32P-labelled RNA probe corresponding to the
human b-globin second exon RNA [26]. GST alone was used as
negative control (Figure 6, lane 1). We showed that the N-terminal
part of IE4 is able to bind directly to RNA in vitro (Figure 6, lane 2)
while the C-terminal part is not (Figure 6, lane 3). More precisely,
the acid-rich region fails to retain RNA (Figure 6 lane 4), while the
arginine-rich Ra, Rc, and predominantly Rb domains are able to
interact with the RNA probe (Figure 6, lanes 5 to 7).
IE4 exports mRNAs in a TAP/NXF1-dependent way
Our data showing that IE4 can interact with export adaptor SR
shuttling proteins and can recruit the export factor TAP/NXF1 in
a RNA-dependent manner clearly suggest a role for IE4 in the
mRNA export pathway. To confirm this role, we used a functional
assay extensively used to study EB2 mRNA export activity. The
reporter plasmid pDM128 has been first described by Hope et al.
[27] (Figure 7A). When transfected into HeLa cells, pDM128
expresses a two-exon, one-intron pre-mRNA which is mostly
spliced, resulting in the excision of the CAT gene and very low
level of CAT protein expressed (Figure 7B, lane 1). As previously
described [28], EB2 expression induces the cytoplasmic accumu-
lation of unspliced mRNAs and, therefore, efficiently increases the
level of CAT protein expressed (Figure 7B, lane 2). Results are
presented with a fixed value of 100 given to the amount of CAT
protein detected in the presence of EB2. When a plasmid
expressing IE4 is cotransfected with pDM128, the amount of
expressed CAT protein reaches a level similar to what can be
observed in the presence of EB2 (Figure 7B, lane 3). However, the
IE4 DCys mutant, which was already shown to localize exclusively
within the nucleus [18], appears to be incompetent in transactivat-
ing this reporter gene (Figure 7B, lane 4), suggesting that the IE4
nucleocytoplasmic shuttling capacity is required for its full activity.
Moreover, the IE4 DRbRc mutant, although not completely
inactive, fails to efficiently increase the amount of CAT protein
detected (Figure 7B, lane 5), suggesting that the RbRc region, due
to its interaction with RNA and the studied SR proteins, is
required for the IE4 mRNA export activity. Finally, the IE4
S136A mutant, which exhibits the same subcellular localization as
the wild-type protein (data not shown), appears also to be able to
transactivate the reporter gene (Figure 7B, lane 6), suggesting that
this phosphorylation site is not important in this mRNA export
assay. Thus, the role of the phosphorylation of IE4 by SRPK1 is
still to be defined.
To address the role of TAP/NXF1 in the IE4-mediated
pDM128 mRNAs export, we used siRNA to knock down TAP/
NXF1 expression. HEK293 cells were transfected with a mix of
four targeted siRNAs for TAP/NXF1 24 h before CAT assays
(Figure 7C). We showed that in cells in which TAP/NXF1 is
knocked down pDM128 mRNAs are not exported anymore and
CAT protein not expressed (Figure 7C, lane 3).
We have also attempted to determine the role of TAP/NXF1
on VZV gene expression (Figure 8). HEK293 cells were
transfected with the siRNAs mix before being mock- (Figure 8,
lanes 1 to 3) or VZV-infected during 36 h (Figure 8, lanes 4 to 6).
Controls were performed without (Figure 8, lanes 1 and 4) or with
a non-targeting siRNAs pool (Figure 8, lanes 2 and 5). The
knockdown of the TAP/NXF1 expression was checked (Figure 8,
lanes 3 and 6) and the presence of different VZV proteins from the
three VZV gene classes was visualized by Western Blotting. The
IE4 protein level is not affected by the TAP/NXF1 knockdown. In
contrast, the ORF9p expression and, to a lesser extent, that of gE
are strongly reduced in cells in which TAP/NXF1 is decreased
(Figure 8, lane 6), suggesting that their transcripts require TAP/
NXF1 to be efficiently exported. The expression level of IE63 and
ORF29p does not seem to be substantially altered by the TAP/
Figure 6. IE4 is able to bind RNA in vitro. Northwestern assay was
performed with the GST-IE4 derivatives as indicated (lanes 2 to 7). Assay
performed with GST alone constituted the negative control (lane 1).
Coomassie Blue-stained gel is shown below.
doi:10.1371/journal.pone.0007882.g006
VZV IE4 as mRNA Export Factor
PLoS ONE | www.plosone.org 7 November 2009 | Volume 4 | Issue 11 | e7882
NXF1 knockdown, suggesting that this requirement could be a
transcript- or a gene class-dependent mechanism.
Discussion
Available data suggest that IE4 acts as an important regulator
on VZV and cellular genes expression and could exert its functions
at a post-transcriptional level. However, the molecular mecha-
nisms are not yet fully characterized. In the present study, we have
attempted to clarify this IE4-mediated gene regulation and identify
some cellular partners of IE4. The main results obtained in this
work can be summarized as follows: (i) In yeast two-hybrid, the
IE4 RbRc domain interacts with cellular proteins involved in
mRNA metabolism. In a cellular context, IE4 interacts with three
Figure 7. IE4 exports pDM128 mRNAs in a TAP/NXF1-dependent manner. (A) Schematic representation of the pDM128 reporter plasmid in
which the CAT coding sequence is inserted into an intronic sequence (adapted from Hiriart et al. 2003). (B) HeLa cells were transfected with the
pDM128 plasmid and expression vectors as indicated (lanes 2 to 6). Assay performed with an empty vector constituted the negative control (lane 1).
CAT protein was quantified by CAT ELISA. Results are presented as a percentage of increase compared to the amount of CAT protein expressed in the
presence of EB2 used as a positive control (lane 2). Expression of the different proteins was verified by Western Blotting with anti-Flag and anti-V5
antibodies. (C) HEK293 cells were transfected with the siRNA mix 24 h before CAT ELISA (lanes 2 and 3). Results are presented as a percentage of
increase compared to the amount of CAT protein expressed in the presence of IE4 without any siRNA (lane 1). Expression of the different proteins was
verified by Western Blotting with anti-IE4 and anti-TAP/NXF1 antibodies.
doi:10.1371/journal.pone.0007882.g007
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shuttling SR proteins, namely ASF/SF2, 9G8 and SRp20, and this
interaction is not bridged by RNA. (ii) IE4 strongly interacts with
the main SR protein kinase, SRPK1, and is phosphorylated in vitro
on residue Ser-136. (iii) IE4 is able to bind RNA in vitro and the
presence of RNA stabilizes complexes containing IE4, TAP/
NXF1 and Aly/REF. (iv) IE4 influences export of mRNAs
through the TAP/NXF1 pathway.
SR proteins are highly conserved non-snRNP proteins whose
roles in mRNA metabolism are increasingly documented. They
were initially described as constitutive and alternative splicing
factors but their activities in mRNA export, translation and
stability are now well established. These data position the SR
proteins as central components in the mRNA processing as well as
highly probable targets in a viral interference on the host
machinery. In retrovirus infections, such as human immunodefi-
ciency virus type 1 (HIV-1) infection, control of alternative splicing
is crucial and a number of studies showed that virion production is
regulated by SR proteins, including ASF/SF2, SC35 and 9G8
[29] while SRp75 acts to upregulate HIV-1 genes expression [30].
In HSV-1 infection, ICP27 was shown to interact with essential
SR splicing factors and to affect their phosphorylation impairing
their ability to function in spliceosome assembly [31,32]. Here we
found a new example of a viral protein which targets the SR
factors as we showed that the VZV IE4 protein interacts with
ASF/SF2, 9G8 and SRp20. Interestingly, the fact that these three
proteins are shuttling proteins suggests that IE4 targets their export
adaptor function rather than their splicing factor activity.
The highly conserved SR protein kinase 1, SRPK1 [23], was
shown to play an important role in the regulation of some
fundamental cellular processes, including the organisation of
components of the nucleus and mRNA processing. This may
explain why SRPK1 appears to be another strategically important
cellular target for several viruses. The E1ˆE4 protein of human
papillomavirus type 1 (HPV-1) was shown to interact and to be
phosphorylated by this kinase [33]. It is still to be determined
whether E1ˆE4 impacts upon SR protein regulation via its
interaction with SRPK1. Such behaviour has already been
emphasized for ICP27 which recruits SRPK1 into the nucleus
where its ability to phosphorylate SR proteins is altered [32]. This
phosphorylation alteration mediates splicing inhibition which leads
to host protein synthesis shut-off and promotes export and
expression of intronless viral transcripts. Collectively, these
findings demonstrate that viruses have adopted mechanisms to
act upon SR proteins as a mean of modifying host gene expression
and affecting viral growth efficiency. Here, although we identified
SRPK1 as a novel cellular partner of VZV IE4, neither nuclear
relocalization of the kinase nor alteration of the SR protein
phosphorylation were highlighted (data not shown). Instead, we
observed that IE4 interacts with SRPK1 in the cytoplasm (data not
shown). Moreover, the phosphorylation mutant appeared to still
be capable to export pDM128 mRNAs, suggesting that the
phosphorylation by SRPK1 is not involved in the exit of IE4 from
the nucleus. Therefore, it could be suggested that IE4 phosphor-
ylation, like the rephosphorylation of shuttling SR proteins in the
cytoplasm, triggers its disassembly from the exported mRNA cargo
and complexes containing TAP/NXF1 and contributes to its
reimport into the nucleus [34], dynamic phenomenon that we
were not able to follow with the techniques that we used.
A characteristic of all known viral mRNA export factors is the
presence of an RNA-binding domain. Indeed, the three IE4
homologous proteins ICP27, UL69 and EB2 were shown to
possess an RNA-binding domain, which is crucial for both in vitro
and in vivo RNA interaction. ICP27 was shown to require an
arginine-glycine-rich region that constitutes an RGG-box RNA-
binding domain [35,36,37] whereas EB2 and UL69 bind RNA
through arginine-rich motifs which resemble other ARM motifs
conserved in many RNA-binding proteins [26,38]. Here, we
showed that the arginine-rich domains of IE4 are also able to bind
RNA in vitro, consolidating the role of IE4 as viral mRNA export
factor.
TAP/NXF1 is the most thoroughly characterized mRNA
export receptor, which interacts directly with the nuclear pore
complex [1]. TAP/NXF1-mediated cellular mRNA export
requires various adaptor proteins that associate with TAP/
NXF1 and mRNP cargoes [2]. The most characterized proteins
are members of the highly conserved Aly/REF family, whose
recruitment to mRNAs depends on the essential mRNA export
factor UAP56 [3]. Moreover, shuttling SR proteins have been
recently proposed to be a second class of adaptors, as ASF/SF2
and 9G8 were shown to associate with TAP/NXF1 [11,39]. These
proteins involved in mRNA export are already known to be
targeted by viral proteins in order to favour viral transcripts
transport. ICP27 and EB2 were shown to bind Aly/REF in an
RNase sensitive manner suggesting that RNA may be a stabilizing
component of the complex [28]. In contrast, UL69 was
demonstrated to bind UAP56 in absence of RNA as bridging
factor [38,40]. In addition to Aly/REF binding, ICP27 and EB2
were also reported to interact with TAP/NXF1 either directly or
via Aly/REF [28,41], which has not yet been shown for UL69.
Figure 8. Knockdown of TAP/NXF1 alters expression of some
VZV proteins. HEK293 cells were not transfected (lanes 1 and 4) or
transfected with the negative siRNA pool (lanes 2 and 5) or the TAP/
NXF1 siRNA pool (lanes 3 and 6) for 24 h followed by mock- (lanes 1 to
3) or VZV-infection for 36 h (lanes 4 to 6). Expression of the different
proteins was verified by Western Blotting with anti-TAP/NXF1, anti-IE4,
anti-IE63, anti-ORF29p, anti-ORF9p, anti-gE and anti-GAPDH (loading
control) antibodies as indicated.
doi:10.1371/journal.pone.0007882.g008
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Here, we highlighted a new example of a viral protein that recruits
TAP/NXF1 and Aly/REF and we showed that the interaction
between IE4 and these proteins is not a direct one but rather
bridged by RNA.
Several studies have shown that the herpesviral mRNA export
factors described above are essential for efficient replication of the
respective herpesviruses and their mRNA export activity appears
to be largely involved. Indeed, the Aly/REF-binding motif of EB2
was demonstrated to be essential both for its mRNA export
function and for production of infectious virions [28]. ICP27 was
shown to recruit Aly/REF to viral replication compartments [41]
and to access the TAP/NXF1 pathway to mediate viral mRNAs
export during HSV-1 infection [42]. The KHSV ORF57
represents another example of viral mRNA export factor and its
interaction with the TREX complex is required for KHSV
intronless mRNAs nuclear export and viral replication [43]. In our
study, we observed that, like EB2, IE4 is able to export the
reporter pDM128 mRNAs. Moreover, we showed that the
nucleocytoplasmic shuttling activity of the protein as well as its
interaction with shuttling SR proteins and RNA are essential to
mediate this nuclear mRNA export. Interestingly, the knockdown
of TAP/NXF1 prevents IE4-mediated export of the reporter
mRNAs, suggesting that IE4 accesses the major cellular mRNA
export pathway to carry its target mRNAs to the cytoplasm. To
determine the role of this mRNA export receptor during a VZV
infection, we also knocked down TAP/NXF1 before infecting cells
and our results indicate that TAP/NXF1 is required for the
correct expression of some VZV genes suggesting a role in the
export of the corresponding mRNAs. Since this observation could
not be generalized to all VZV genes, we suggested that this TAP/
NXF1 requirement could be a transcript- or a gene class-
dependent mechanism but this specificity needs to be further
explored.
All these data suggest a general mechanism for the herpesviral
mRNA export factors which bind to specific viral mRNAs and
recruit these transcripts to the cellular mRNA export TAP/NXF1
pathway through interaction with one of its adaptors such as Aly/
REF, UAP56 or the shuttling SR proteins. The IE4-mediated
mRNA export model is summarized in Figure 9. Interestingly, in
our yeast two-hybrid screen, the THO complex 2 protein was also
highlighted. THO proteins are known to associate with UAP56
and Aly/REF to form the elongation TREX complex. Although
this interaction between IE4 and THO2 is still to be investigated,
IE4 could be co-transcriptionally recruited to mRNAs and thus
could couple viral transcription with nuclear export of viral
mRNAs.
Materials and Methods
Cells
HeLa cells, a human epithelial cell line from a fatal cervical
carcinoma transformed by human papillomavirus 18, and MeWo
cells, a continuous human melanoma cell line, were grown in
Eagle’s Minimum Essential Medium (EMEM) (BioWhittaker)
supplemented with 10% foetal bovine serum (FBS) (BioWhittaker)
and 1% L-glutamine (BioWhittaker). HEK293 cells, a human
embryonic kidney cell line, were grown in Dulbecco’s Modifica-
tion of Eagle’s Medium (DMEM) (BioWhittaker) supplemented
with 10% foetal bovine serum, 1% L-glutamine and 1% Non-
Essential Amino Acid (BioWhittaker).
Plasmids
The pcDNA3.12-IE4 plasmid was described previously [18].
For the V5 epitope-tagged constructs (Figure 1C), the different IE4
gene portions were amplified by PCR from the pcDNA3.12-IE4
and cloned by TA cloning in the pcDNA3.1/V5-His-TOPO
(Invitrogen) according to the manufacturer’s instructions. For the
GST fusion derivatives (Figure 1D), the different portions of the
IE4 gene were amplified by PCR from pcDNA3.12-IE4 and
cloned in the pGEX-5x (Amersham Biosciences). Mutations were
introduced into the IE4 gene by PCR using the QuickChange site-
directed mutagenesis kit system (Stratagene). In pGBKT7-IE4
RbRc (Figure 1A), BamHI-EcoRI IE4 RbRc sequence was inserted
in frame with the Gal4 DNA-binding domain into the pGBKT7
(BD Biosciences). ASF/SF2, 9G8 and SRp20 coding sequences
were amplified by PCR from the yeast-purified corresponding
pGADT7 vectors (BD Clontech). These genes were cloned in the
pcDNA3.1/V5-His-TOPO (Invitrogen), pCMV-HA (BD Clon-
tech) or pGEX-5x (Amersham Biosciences) vectors in order to
produce carboxy V5- and amino HA-epitope tagged constructs or
GST fusion proteins respectively. All our constructions were
subsequently verified by sequencing. The GST-REF and GST-
TAP constructs have been described elsewhere [44] and were a
generous gift from Dr. E. Izaurralde. The pCiF.EB2, encoding
Flag-tagged EB2, was described previously [45]. The pRSETb-
SRPK1, encoding His-tagged SRPK1, and pFlag-SRPKI plasmids
were kindly provided by Dr. R. Sandri-Goldin. The reporter
plasmid pDM128 has been described elsewhere [27] and was a
generous gift from Dr. B. R. Cullen.
Yeast Two-Hybrid Assay
Plasmid pGBKT7-IE4 RbRc was transformed into a mating
suitable AH109 Saccharomyces cerevisiae strain. HeLa cDNA library,
Figure 9. IE4-mediated mRNA export model. In this study,
Varicella-Zoster virus (VZV) IE4 protein was shown to interact in the
nucleus with shuttling SR proteins. These SR proteins have been
previously shown to mediate interaction between intronless mRNAs
and TAP/NXF1. Moreover, IE4 could be co-transcriptionally recruited to
nascent mRNAs by interaction with THO proteins of the TREX complex.
In addition, we have shown that IE4 is present in complexes containing
TAP/NXF1 as well as Aly/REF and that these complexes are stabilized by
the presence of RNA. The nucleocytoplasmic capacity of IE4, as well as
its interaction with RNA and the SR proteins, have been shown to be
required for its mRNA export activity. Finally, we have shown that IE4 is
phosphorylated by the main SR protein kinase SRPK1, and this IE4
phosphorylation in the cytoplasm could trigger its disassembly from the
exported mRNA cargo and contributes to its reimport, like it has been
previously shown for the shuttling SR proteins.
doi:10.1371/journal.pone.0007882.g009
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fused to the Gal4 activation domain into the pGADT7, was
provided into Y187 Saccharomyces cerevisiae strain (BD Clontech).
After mating of the two strains, co-transformants were plated on
media lacking tryptophan, leucine and histidine, and then were
screened for b-galactosidase production. Blue colonies, scored as
positive interactions, were purified, amplified by PCR and
sequenced.
Transient Transfection and Infection
HeLa cells were transfected for 24 h before immunoprecipita-
tion analysis, and for 48 h before CAT assay and His-SRPK1
purification. MeWo cells were transfected for 8 h before VZV
infection, followed by 24 h post-infection immunoprecipitation
analysis. The VZV NIK strain (a kind gift from Dr. A.F. Nikkels)
was used to infect MeWo and HEK293 cells. All plasmid
transfections were performed using JetPEITM transfectant rea-
gent (Polyplus Transfection) according to the manufacturer’s
instructions.
Nuclear and Total Protein Extraction
HeLa nuclear extracts were obtained by successive incubation
in hypotonic (10 mM Hepes-KOH, pH 7.9, 2 mM MgCl2,
0.1 mM EDTA, 10 mM KCl, 0.5% NP-40) and hypertonic
buffer (50 mM Hepes-KOH, pH 7.9, 2 mM MgCl2, 0.1 mM
EDTA, 50 mM KCl, 400 mM NaCl, 10% glycerol). HeLa and
MeWo total extracts were obtained by cell lysis in immunopre-
cipitation buffer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl,
1 mM EDTA, 1 mM EGTA, 1% NP-40, 10% glycerol) or in
lysis buffer (50 mM Hepes-KOH, pH 8, 0.3 M NaCl, 1% Triton
X-100). HEK293 total extracts were obtained by cell lysis in lysis
buffer (25 mM Hepes-KOH, pH 7.5, 150 mM NaCl, 0.5%
Triton X-100) or in lysis buffer B (30 mM Tris-HCl, pH 7,
250 mM NaCl, 1 mM EDTA, 0.1% Triton X-100, 5% glycerol)
for in vitro binding assay. Mixture of phosphatase inhibitors (1 mM
Na3VO4, 1 mM phenylmethylsulfonyl fluoride, 10 mM NaF and
25 mM b-glycerophosphate) and Complete protease inhibitors
(Roche) were extemporaneously added in all buffers. Protein
concentration was determined with a Bio-Rad protein assay.
Immunoprecipitation
For transfected SR proteins immunoprecipitation, protein A-
agarose beads (Pierce) were saturated in SR wash buffer (50 mM
Tris-HCl, pH 7.4, 100 mM KCl, 0.1% NP-40) for 2 h at 4uC with
anti-HA (Roche), anti-V5 (Invitrogen) or anti-GFP (SantaCruz)
antibodies as indicated. HeLa nuclear extracts, treated or not for
30 min at 37uC with RNases A/T1 mix (Fermentas), were
incubated with antibody-coupled beads for 4 h at 4uC in SR
immunoprecipitation buffer (50 mM Tris-HCl, pH 7.4, 100 mM
KCl, 5 mM MgCl2, 0.1% NP-40, 10% glycerol). Beads were
washed in SR wash buffer and bound proteins were eluted by
boiling for 2 min in SDS sample buffer. For endogenous SR
proteins immunoprecipitation, protein A-agarose beads (Pierce)
were saturated in immunoprecipitation buffer (see above) for 2 h
at 4uC with anti-Flag (Sigma) or anti-V5 (Invitrogen) antibodies as
indicated. HeLa total extracts were incubated with antibody-
coupled beads overnight at 4uC in immunoprecipitation buffer.
Beads were washed in immunoprecipitation buffer and bound
proteins were eluted by boiling for 2 min in SDS sample buffer.
For TAP/NXF1 and Aly/REF immunoprecipitation, MeWo total
extracts, treated or not for 45 min at 37uC with RNases A/T1 mix
(Fermentas), were precleared for 1 h at 4uC with normal rabbit or
mouse IgG (SantaCruz). Extracts were then incubated for 2 h at
4uC with anti-IE4 [46], anti-TAP/NXF1 (Abcam), anti-Aly/REF
(Abcam), anti-GFP (SantaCruz) or anti-Flag (Sigma) antibodies as
indicated. Protein A-sepharose beads (GE Healthcare) were added
for 2 h at 4uC. The precipitated were washed with lysis buffer and
bound proteins were eluted by boiling for 2 min in SDS sample
buffer. For SRPK1 immunoprecipitation, protein A-agarose beads
(Pierce) were saturated in immunoprecipitation buffer (see above)
for 2 h at 4uC with anti-IE4 [46], anti-Flag (Sigma), anti-V5
(Invitrogen) or anti-GFP (SantaCruz) antibodies as indicated.
MeWo total extracts were incubated with antibody-coupled beads
overnight at 4uC in immunoprecipitation buffer. Beads were
washed in immunoprecipitation buffer and bound proteins were
eluted by boiling for 2 min in SDS sample buffer.
Recombinant Proteins
The various pGEX-5x-constructs were transformed in Esche-
richia coli BL21 strain and GST fusion proteins were expressed
following classical induction with 0.1 mM isopropyl-1-thio-b-D-
galactopyranoside (IPTG) for 4 h at 37uC. Lysates were prepared
using MTPBS (150 mM NaCl, 16 mM Na2HPO4, 4 mM
NaH2PO4, 100 mM EDTA, 1% Triton X-100, 1 mM PMSF,
pH 7.3). Following four cycles of sonication, bacterial debris were
removed by centrifugation. Proteins were then purified on
glutathione-Sepharose 4B affinity beads (Amersham Biosciences),
followed by extensive washing in MTPBS. SRPK1 active kinase
was purified from pRSETb-SRPK1 transfected HeLa cells.
ProBond Purification System (Invitrogen), for purification of
polyhistidine-containing recombinant proteins, was used accord-
ing to the manufacturer’s instructions. Purification was performed
under native conditions in order to preserve protein activity.
Protein concentration was determined with a Bio-Rad protein
assay.
In Vitro Transcription/Translation
Proteins were expressed from pcDNA3.1/V5-His-TOPO,
which contains a T7 promoter, and labelled with [35S]-methionine
(Perkin Elmer) using the in vitro TNT-T7-coupled reticulocyte
lysate system (Promega) according to the manufacturer’s
instructions.
In Vitro Binding Assays
In radioactive binding assays, 35S-labelled proteins were
incubated with GST fusion protein-coupled Sepharose beads in
binding buffer (10 mM Tris-HCl, pH 8, 150 mM NaCl, 0.1%
NP-40, 1 mM PMSF). Assay performed with GST alone
constituted the negative control. Binding reactions were allowed
to take place overnight at 4uC. Beads were washed in binding
buffer. Bound proteins were eluted by boiling for 2 min in SDS
sample buffer, followed by loading on 10% SDS-PAGE. Gels were
subsequently transferred and autoradiographed. In non-radioac-
tive binding assays, GST fusion protein-coupled Sepharose beads
were incubated with HEK293 total extracts in MTPBS. Assay
performed with GST alone constituted the negative control.
Binding reactions were allowed to take place overnight at 4uC.
Beads were extensively washed in MTPBS and bound proteins
were eluted by boiling for 2 min in SDS sample buffer.
In Vitro Kinase Assays
Equal amounts of GST fusion protein-coupled Sepharose beads
were incubated with 2 units of recombinant SRPK1 (Upstate Cell
Signalling) or 10 mg of purified His-SRPK1 in kinase assay buffer
(50 mM Tris-HCl, pH 7.4, 10 mM MgCl2, 2 mM ATP) contain-
ing 5 mCi of [c-32P]-ATP (Perkin Elmer). Assay performed with
GST alone constituted the negative control. Kinase reactions were
allowed to take place for 30 min at 30uC. Beads were washed once
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in MTBPS. Bound proteins were eluted by boiling for 2 min in
SDS sample buffer, followed by loading on 10% SDS-PAGE. Gels
were subsequently transferred and autoradiographed.
Western Blotting
Eluted proteins were subjected to SDS-polyacrylamide gel
electrophoresis (PAGE) and Western Blot analysis was used to
detect the co-immunoprecipitated proteins. Endogenous ASF/SF2
and SRp20 were detected with anti-SF2/ASF (SantaCruz) and
anti-SR protein (Zymed). Endogenous SRPK1 kinase was detected
with anti-SRPK1 (BD Transduction). Endogenous TAP/NXF1
and Aly/REF were detected with anti-TAP/NXF1 and anti-Aly/
REF (Abcam). Endogenous GAPDH was detected with anti-
GAPDH (Ambion). Anti-IE4 [46] and anti-IE63 [47] have been
previously described. Anti-ORF29p has been described elsewhere
[48] and was a generous gift from Dr. Cohrs. Anti-gE (VL8) and
anti-ORF9p were produced in our laboratory.
Northwestern Blotting
Northwestern blots were performed essentially as described
previously [49]. Briefly, GST fusion proteins were subjected to
SDS-PAGE, transferred to a PVDF membrane and then
denatured and renatured. The membrane was successively
incubated with a 32P-labelled 180-nt RNA probe corresponding
to the human b-globin second exon and then autoradiographed.
CAT Assays
The reporter plasmid pDM128 has been described elsewhere
[27]. CAT protein expression was evaluated using CAT enzyme-
linked immunosorbent assay (ELISA) kit (Roche Applied Sciences)
according to the manufacturer’s instructions. Assay performed
with an empty vector constituted the negative control.
siRNA transfection
ON-TARGETplus SMARTpool of siRNAs directed against
TAP/NXF1 (013680) and ON-TARGETplus Non-targeting pool
(001810) were synthesized by Dharmacon Inc. Transfections were
performed with 100 pmol of the siRNA pools into HEK293 cells
using ProFection Mammalian Transfection System - Calcium
Phosphate (Promega) according to the manufacturer’s protocol.
After 24 h, cells were transfected for CAT assays or VZV-infected
during 36 h for Western Blot analysis. TAP/NXF1 knockdown
was confirmed at both protein level by Western Blot analysis and
RNA level by qRT-PCR (data not shown).
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